Waitemata District Health Board Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2011
NCT00994903
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Waitemata District Health Board

Active Ingredients

Drugs in Phase 3 Trials (4)

magnesium citrate (1 trial)

phylloquinone (1 trial)

simvastatin (zocor) (1 trial)

sodium thiosulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Intestinal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4